About TOMORROW Prenatal Test

TOMORROW Prenatal Test is a new CGC Genetics test performed in maternal blood and based on a non-invasive technique to investigate the presence of trisomy of chromosomes 21, 18 and 13 in fetal DNA, to identify fetal gender and
to detect aneuploidies of sex chromosomes (Monosomy X, XXX, XXY, XYY), as early as 10 weeks of pregnancy.

TOMORROW test determines

Trisomies

Trisomy 21

Trisomy 18

Trisomy 13

Sex chromosome aneuploidies

Monosomy X

XXX

XXY

XYY

Fetal gender

Male / Female

WHO SHOULD USE TOMORROW PRENATAL TEST?

PREGNANT WOMEN AT ANY AGE AND RISK STATUS

TOMORROW Prenatal Test, has been clinically validated to be performed on pregnant women at any age or risk status, but it is especially recommended for:

  • Pregnant women who wish to screen for the presence of these chromosomal aneuploidies in the fetus without going through an invasive procedure.
  • Pregnant women 35+ years-old.
  • Pregnant women with increased risk for trisomies 21, 18 and 13.
  • Pregnant women with diagnosed trisomy in previous pregnancy.
  • Pregnant women with recurrent abortions history.
  • Pregnant women who wish to know more about her baby.

TOMORROW Prenatal Test test can also be performed in:

  • Twin pregnancies (2 fetuses)*
  • IVF/Egg donation (self-donation or not)

 

*Detection of trisomies 21, 18 and 13 and fetal gender identification. Test cannot be performed in case of pregnancies with more than 2 fetuses. Fetal gender identification is performed by detecting the presence or absence of Y chromosome in maternal blood. In case of Y chromosome detection in twin pregnancy (2 fetuses), it is not possible to confirm if one or both fetuses are male.

WHAT DOES TOMORROW PRENATAL TEST INCLUDE?



  • T21
    T18
    T13
    Fetal Gender Identification
    Sex chromosome aneuploidies:
    Monosomy X, XXX, XXY, XYY


CGC Genetics offers an optional solution: 

  • T21, T18, T13 only: Detection of trisomies 21, 18 and 13 and fetal gender identification.

Because TOMORROW is so important today

EARLY DETECTION

Can be performed as early as 10 weeks of pregnancy.

SAFE

No risk of abortion, usually associated with invasive procedures.

SIMPLE

Only a simple blood collection required; no prior preparation.

HIGH DETECTION RATE

Detection of the most common genetic syndromes.

RELIABLE ANALYSIS

False positive and false negative rate is less than 0.5%.

TURNAROUND TIME

Average: 6 business days (maximum 10).